Article
A first-in-class cell-based therapy holds promise for better treatment of chronic venous ulcers. Surprisingly, the less intense regimen - fewer cells, administered less often - proved to be the more effective of the options studied, according to results published online Aug. 2 in The Lancet.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.